Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00407459
Status:
COMPLETED
Last Update Posted:
2011-09-02
First Post:
2006-12-04
Brief Title:
Phase II Study of Bevacizumab Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma
Sponsor:
Organization:
Istituto Clinico Humanitas